p53-Luc/EF1α-mCherry Reporter Cell Line - HeLa

p53-Luc/EF1α-mCherry Reporter Cell Line - HeLa is a dual-reporter human cervical cancer cell line engineered to enable sensitive monitoring of p53 transcriptional activity and reliable normalization of cell number or transfection-related variation. The cell line is based on HeLa cells and contains a luciferase reporter driven by a p53-responsive promoter, allowing changes in p53 pathway activation to be quantified through luminescence. In parallel, constitutive expression of mCherry under the human EF1α promoter provides a stable fluorescent signal for visualization, cell tracking, and viability-associated normalization. This dual-reporter design combines the high sensitivity and broad dynamic range of luciferase detection with the convenience of red fluorescent imaging. By providing simultaneous pathway-specific and constitutive reporter signals, this model supports reproducible assessment of p53 signaling in a well-established human cancer cell background.

The p53-Luc/EF1α-mCherry Reporter Cell Line - HeLa is particularly useful for screening compounds that activate, restore, inhibit, or otherwise modulate the p53 pathway. It can be applied in oncology drug discovery to identify DNA-damaging agents, MDM2-p53 interaction inhibitors, kinase inhibitors, epigenetic modulators, and other molecules that influence p53-dependent transcription. Luciferase output enables rapid quantitative comparison across treatment concentrations and time points, while the mCherry signal helps distinguish genuine pathway activation from apparent changes caused by cell loss, proliferation differences, or uneven cell seeding. The reporter line is also appropriate for mechanistic studies of genotoxic stress, DNA repair, apoptosis, cell-cycle regulation, oxidative stress, and viral or host factors affecting p53 function. In high-content or high-throughput workflows, mCherry fluorescence can facilitate automated cell identification and normalization, whereas p53-driven luciferase provides a sensitive functional endpoint.